tert-butyl 3-(2-hydroxyethoxy)azetidine-1-carboxylate, 95.0%, 1g

(R)-(+)-1-(4-Methoxyphenyl)ethylamine, 96.0%, 25g

N-(2-(2-Methoxy-4-(methylsulfonamido)-5-phenoxyphenyl)-2-oxoethyl)formamide, 97%, 5g

(7-Amino-2-oxo-2H-chromen-4-yl)acetic acid, 95.0%, 1g

SSR128129E, 95.0%, 1mg

[S(R)]-N-[(1S)-2-(Diphenylphosphino)-1-[2-(diphenylphosphino)phenyl]ethyl]]-2-methyl-N,2-dimethyl-2-propanesulfinamide, 95%, 50mg

N-METHOXY-N-METHYLISOXAZOLE-3-CARBOXAMIDE, 95.0%, 5g

Diosmina, mínimo 95 %, 100 g, envase de vidrio

N-(4-Hydroxyphenethyl)acetamide, 95.0%, 5g

1,2-Bis(4-chlorophenyl)ethyne, 99%, 1g

Ethyl 2-Acetyl-3-(dimethylamino)acrylate>95.0%(GC)(T)5g

8-Nitro-7-quinolinecarboxaldehyde>98.0%(GC)(T)1g

4-Nitrophthalamide, 95.0%, 25g